CD8A and COVID-19: In addition, in COVID-19 patients, the dominant effector CD8+ T cells were GzmA, GzmB, and perforin triple-positive cells, compared with uninfected individuals; patients expressing effector CD8+ T cells that produce multiple virulence molecules exhibited milder symptoms (Westmeier et al., 2020), which may indicate a potential protective mechanism.